Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Dompe Farmaceutici
Deal Size : $54.0 million
Deal Type : Series A Financing
Details : The financing will be used to invest in Engitix’s internal drug discovery pipeline through IND-enabling studies, expand its ECM discovery platform and bioinformatics capabilities into new therapeutic areas, and to expand its team, facilities and operat...
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
January 19, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Dompe Farmaceutici
Deal Size : $54.0 million
Deal Type : Series A Financing
Lead Product(s) : Undisclosed
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Discovery Platform
Sponsor : Takeda Pharmaceutical
Deal Size : $500.0 million
Deal Type : Collaboration
Details : Under the terms of the agreement, Takeda will have exclusive rights to develop and commercialise clinical candidates generated against validated targets derived from the collaboration.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
August 25, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Discovery Platform
Sponsor : Takeda Pharmaceutical
Deal Size : $500.0 million
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?
Reset All
